Moxiclav (Amoxicillin, Clavulanic Acid)

Amoxicillin interferes with bacterial cell‑wall synthesis by binding to penicillin‑binding proteins, causing cell lysis. Clavulanic acid blocks β‑lactamase enzymes that many bacteria produce to inactivate penicillins, thereby protecting amoxicillin and extending its activity against resistant strains.

The dosage of Moxiclav is individualized by the prescribing clinician based on the infection type, severity, patient age, weight, and renal function. Healthcare professionals determine the appropriate strength, frequency, and duration according to current clinical guidelines.

Safety data for amoxicillin/clavulanic acid in pregnancy are limited, so it should only be used when the potential benefit justifies any possible risk to the fetus. Breastfeeding mothers should consult their physician, as small amounts may be excreted in milk.

To request Moxiclav, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Plain amoxicillin lacks a β‑lactamase inhibitor, so it may be ineffective against bacteria that produce β‑lactamase enzymes. Adding clavulanic acid in Moxiclav broadens the spectrum, allowing treatment of infections caused by resistant strains that would otherwise degrade amoxicillin alone.

Moxiclav tablets should be stored at temperatures below 25 °C, in their original container, protected from moisture and direct sunlight. Keeping the product in a dry, cool place helps maintain its potency throughout the shelf life.

Moxiclav is taken orally, usually with food or a full glass of water to reduce gastrointestinal upset. The tablet should be swallowed whole; it is not intended for crushing, chewing, or dissolving unless a specific formulation advises otherwise.

Serious adverse events include severe allergic reactions such as anaphylaxis, Clostridioides difficile‑associated colitis, and rare skin conditions like Stevens‑Johnson syndrome. Patients should seek immediate medical attention if they experience difficulty breathing, severe rash, or persistent diarrhea.

Moxiclav is contraindicated in individuals with a known hypersensitivity to amoxicillin, other penicillins, or clavulanic acid. It should also be avoided in patients who have experienced severe reactions to β‑lactam antibiotics in the past.